UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013304
Receipt number R000015088
Scientific Title Phase I study of concurrent chemoradiotherapy with docetaxel,cisplatin and 5-fluorouracil (DCF) in patients with locally advanced cancer of the external auditory canal and middle ear.
Date of disclosure of the study information 2014/03/01
Last modified on 2014/01/20 22:25:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase I study of concurrent chemoradiotherapy with docetaxel,cisplatin and 5-fluorouracil (DCF) in patients with locally advanced cancer of the external auditory canal and middle ear.

Acronym

Phase I study of CCRT with DCF for advanced ear cancer

Scientific Title

Phase I study of concurrent chemoradiotherapy with docetaxel,cisplatin and 5-fluorouracil (DCF) in patients with locally advanced cancer of the external auditory canal and middle ear.

Scientific Title:Acronym

Phase I study of CCRT with DCF for advanced ear cancer

Region

Japan


Condition

Condition

Neoplasm of the external auditory canal and middle ear

Classification by specialty

Hematology and clinical oncology Oto-rhino-laryngology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

to evaluate the safety of concurrent chemoradiotherapy with docetaxel,cisplatin and 5-fluorouracil (DCF) in patients with locally advanced cancer of the external auditory canal and middle ear.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

Maximum tolerated dose and recommended dose

Key secondary outcomes

frequency and severity of side effects


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Concurrent chemoradiotherapy
docetaxel 40-60 mg/m2/day day1 iv
cisplatin 70 mg/m2/day day1 iv
5-fluorouracil 700 mg/m2/day day1-5 civ
q4w , 2 cycle
RT 66Gy/33fr/7w
Radiotherapy starts on day1.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Histologically proven squamous cell carcinoma of the external auditory canal or middle ear
2) Primary lesion is located in the external auditory canal or middle ear
3) With T3 and T4 tumors in Pittsburgh tumor staging system (modified in 2000)
4) Patients with T3 tumors rejecting operation
5) No previous treatment of ear cancer without excisional biopsy or unresectable reccurrent tumor
6) No distant organ metastases
7) Aged 20 to 75 years old
8) ECOG PS of 0 or 1
9) No previous radiotherapy in head and neck lesion or radiologist permits curative additional radiotherapy
10) No previous chemotherapy within three years
11) Adequate organ functions
12) Written informed consent

Key exclusion criteria

1) Pregnant or lactating women or women of childbearing potential
2) Psychosis
3) Patients requiring systemic steroids medication
4) HBs antigen positive
5) HCV antibody positive
6) HIV antibody positive
7) Uncontrollable diabetes millutus
8) History of myocardial infarction within three months
9) History of unstable angina pectoris or interstitial pneumonia or fibroid lung or severe emphysema
10) Active bacterial or fungous infection
11) In case of judge as inadequate subjects by attending physician

Target sample size

12


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shingo Hasegawa, M.D, PhD

Organization

Kobe University Hospital

Division name

Otolaryngology-Head & Neck Surgery

Zip code


Address

7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017 JAPAN

TEL

0783825111

Email

shingo@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shingo Hasegawa, M.D, PhD

Organization

Kobe University Hospital

Division name

Otolaryngology-Head & Neck Surgery

Zip code


Address

7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017 JAPAN

TEL

0783825111

Homepage URL


Email

shingo@med.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2014 Year 02 Month 28 Day

Date of IRB


Anticipated trial start date

2014 Year 03 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 02 Month 28 Day

Last modified on

2014 Year 01 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015088


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name